Skip to main content

Table 2 Statistical analysis

From: The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner

Group Comparisons*

Χ 2

P-Value

Bz v. Control

0.868

0.349

Bz → HB v. Control

1.044

0.307

HB → Bz v . Control

3.884

0.049

Bz → HB v. Bz

0.001

0.972

HB → Bz v. Bz

1.058

0.304

HB → Bz v. Bz →HB

1.324

0.250

  1. * Statistical comparisons between groups were calculated as described in Materials and Methods. The arrow denotes the order of treatments. Bz = Bortezomib, HB = HB 22.7. N = 5 mice per group; p < 0.05 is considered significant.
Back to article page

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us